COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1930: Articles 19291-19300  | Next

Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts
Tran, T. N.-A., Wikle, N., Albert, J., Inam, H., Strong, E. R., Brinda, K., Leighow, S. M., Yang, F., Hossain, S., Pritchard, J. R., Chan, P., Hanage, W. P., Hanks, E. M., Boni, M. F.
10.1101/2021.01.12.21249694 — Posted: 2021-01-15 Discussion: Offsite
Optimal piecewise constant vaccination and lockdown policies for COVID-19
Salcedo-Varea, G. A., Penunuri, F., Gonzalez-Sanchez, D., Diaz-Infante, S.
10.1101/2021.01.13.21249773 — Posted: 2021-01-15
Modelling the Spreading of the SARS-CoV-2 in Presence of the Lockdown and Quarantine Measures by a "Kinetic-Type Reactions" Approach
SONNINO, G., PEETERS, P., NARDONE, P.
10.1101/2021.01.14.21249797 — Posted: 2021-01-15
Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England
Gravagnuolo, A. M., Faqih, L., Cronshaw, C., Wynn, J., Burglin, L., Klapper, P., Wigglesworth, M.
10.1101/2021.01.14.21249386 — Posted: 2021-01-15
Direct Simulation of the CoVid-19 epidemic
Cabrera-Becerril, A., Peralta, R., Miramontes, P.
10.1101/2021.01.14.21249829 — Posted: 2021-01-15
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., Munro, K., Wallace, S., Kirwan, P. D., Shrotri, M., Vusirikala, A., Rokadiya, S., Kall, M., Zambon, M., Ramsay, M., Brooks, T., SIREN Sudy Group, , Brown, C. S., Chand, M. A., Hopkins, S.
10.1101/2021.01.13.21249642 — Posted: 2021-01-15 Discussion: Onsite | Offsite
Importance of patient bed pathways and length of stay differences in predicting COVID-19 bed occupancy in England
Leclerc, Q. J., Fuller, N. M., Keogh, R. H., Diaz-Ordaz, K., Sekula, R., Semple, M. G., ISARIC4C Investigators, , CMMID COVID-19 Working Group, , Atkins, K. E., Procter, S. R., Knight, G. M.
10.1101/2021.01.14.21249791 — Posted: 2021-01-15
Development of at-home sample collection logistics for large scale SARS-CoV-2 seroprevalence studies
Aatresh, A. V., Cummings, K., Gerstein, H., Knight, C. S., Limberopolous, A., Stasi, M. A., Bedugnis, A., Somberg, K. A., Franca, C. T., Mina, M. J.
10.1101/2021.01.14.21249824 — Posted: 2021-01-15
Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics
Ma, K. C., Menkir, T., Kissler, S., Grad, Y., Lipsitch, M.
10.1101/2021.01.15.21249881 — Posted: 2021-01-15
Variability of Individual Infectiousness Derived from Aggregate Statistics of COVID-19
Kirkegaard, J. B., Sneppen, K.
10.1101/2021.01.15.21249870 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).